← Leaderboards
Nicole Marie Fisher
Vanderbilt University
$87,630
Attributed
$87,630
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $29.7K · FY2017–19$50K$37.5K$25K$12.5K$0
'17
'18
'19
Funding mix
By agency
NIH$87,630 · 1
By mechanism
F31$87,630 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- P Jeffrey Conn$37,782,937
- Craig Lindsley$38,671,033
- Rocco George Gogliotti$3,490,212
- Carrie Kimberly Jones$9,423,953
- Jerri Michelle Rook$4,711,471
Others in their field
Other Emerging Leaders on “Animals”
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ted Ross · University Of Georgia$70,992,558
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,986,959
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,241,299
Research focus
AnimalsApneaAutopsyBackBehaviorBehavior TestBrainBrain RegionCerebellumChemosensitizationChildCognitionCognitiveConditioned FearCorpus Striatum StructureDiagnosisElectrophysiology (Science)Excitatory Postsynaptic PotentialsExhibitsExtinction (Psychology)Fear MemoryFemaleFreezingAffect
Grant awards (3)
Metabotropic Glutamate Receptor 7 as a Novel Therapeutic Target for MECP2 Duplication Syndrome$29,698
F31 · FY2019 · MH · contact PI
Metabotropic Glutamate Receptor 7 as a Novel Therapeutic Target for MECP2 Duplication Syndrome$29,206
F31 · FY2018 · MH · contact PI
Metabotropic Glutamate Receptor 7 as a Novel Therapeutic Target for MECP2 Duplication Syndrome$28,726
F31 · FY2017 · MH · contact PI